In May 2007, the FDA announced a public health advisory regarding patients with kidney disease and MRI/MRA contrast dyes.
Gadolinium Injections
An MRI contrast dye, gadolinium, based injections can impair kidney function and lead to a potentially fatal disorder. This disorder, Nephrogenic Systemic Fibrosis, results in a formation of thick and hardening skin on the limbs and could involve scarring of internal organs. This disease is also referred to as Nephrogenic Fibrosing Dermopathy(NFD).
On May 29, 2007 the Danish equivalent of the United States food and drug administration (FDA) reported a link in 25 patients with Gadolinium based contrast agents and Nephrogenic Systemic Fibrosis.
On May 23rd, 2007 the FDA announced a public health advisory regarding patients with kidney disease and the MRI/MRA contrast dyes. In fact, the FDA now requires a black box warning on all MRI/MRA contrast dyes that contain gadolinium.
Symptoms of NSF/NFD include:
| — |
burning of the skin |
| — |
hardening or tightening of skin |
| — |
itching & swelling of the skin |
| — |
muscle weakness |
Did You Receieve a Gadolinium Injection During an MRI / MRA?
If you or a loved were injected with a gadolinium contrast agent during an MRI or MRA and developed Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermotherapy (NSF / NFD), you have legal rights. Kidney failure patients who developed this serious skin disorder should contact our lawyers today for a FREE case review. Please call 1-800-749-3221 and we will contact you about your potential gadolinium case.
Consult A Doctor On Medical Issues
The Steinberg law firm does not intend, by this web site or otherwise, to dissuade anyone from taking medication without their doctors' approval. Please consult your doctor, not your lawyer, on matters relating to your health. Patients should talk to their physicians to decide whether they are at risk with Gadolinium injections.
